Shilpa Medicare Announce USFDA Approval for ANDA, Imatinib Mesylate Tablets, 100 mg and 400 mg. 글 내용 전체보기
AstraZeneca Announce Brilinta’s Phase III THEMIS trial met primary endpoint in patients with established coronary artery disease and type-2 diabetes 글 내용 전체보기
To Develop Innovative Models for Clinical Trials Ochsner Health System and Pfizer Enter Partnership 글 내용 전체보기
FDA issues warning letter to clinic illegally marketing unapproved thermography device, warns consumers to avoid using thermography devices to detect breast cancer 글 내용 전체보기
